Biogen/Capsigen Ink Up To $1.3bn Deal For Improved AAV Capsids
Collaboration Is Latest Focused On Next-Generation Gene Therapies
Biogen is Capsigen’s first partner, while Dyno Therapeutics has also entered into deals potentially worth billions with large drug and biotech firms.
